Health Canada17 Jul 2026
Atellica® CH Urine Albumin (UAlb)
Health Canada published a recall notice for Atellica® CH Urine Albumin (UAlb) on 17 Jul 2026. It is one of 311 notices of this kind from Health Canada since 2 Apr 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Health Canada
- Issued
- 17 Jul 2026
- Recall type
- Health product recall
- Companies
- Siemens Healthcare Diagnostics Inc.511 Benedict Ave, Tarrytown, New York, United States, 10591
- Official source
- Health Canada: the notice at its source
The latest from Health CanadaEvery warning and recall in Canada
Source: Health Canada: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains information licensed under the Open Government Licence – Canada.
The notice as issued
Issue: Siemens Healthineers has confirmed, through the investigation of customer complaints, the potential for the following issues associated with processing Atellica CH Urine Albumin (UAlb) tests on Atellica CH and Atellica CI analyzers.• Falsely depressed Atellica CH Urea Nitrogen (UN_c) results• Falsely depressed Atellica CH Enzymatic Hemoglobin A1c (A1c_E) results• Increased rate of reaction cuvette QC failuresThese issues may impact quality control (QC), calibrators, and patient results for the UN_c and A1c_E assays across all sample types. Additional information Details Original published date: 2026-07-17 Affected products: Affected products Lot or serial number Model or catalogue number Atellica® CH Urine Albumin (UAlb) More than 10 numbers, contact manufacturer. 11537225 Issue
Source: Health Canada: the notice at its source. The text is the agency's, unedited. Contains information licensed under the Open Government Licence – Canada.